Last reviewed · How we verify

NCT03880084: NIVILIUM

Delirium, Agitation/Sedation, Pain and Dyspnea in Respiratory Intensive Care Unit (NIVILIUM)

Status unknown Last updated 10 May 2023
What this trial tests

trial testing Observation in Respiratory Failure in 92 participants. Status unknown.

Timeline
1 August 2019
Primary endpoint
1 August 2020
1 January 2025

Quick facts

Lead sponsorUniversity of Modena and Reggio Emilia
StatusStatus unknown
Study typeOBSERVATIONAL
Enrollment92
Start date1 August 2019
Primary completion1 August 2020
Estimated completion1 January 2025
Sites1 location across Italy

Drugs / interventions tested

Conditions studied

Sponsor

University of Modena and Reggio Emilia

Who can join

18 and older, any sex, with Respiratory Failure or Delirium. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Non-Invasive Mechanical Ventilation (NIV) has been increasingly used in the treatment of acute respiratory failure. Notwithstanding failure rates still remains high, ranging from 5% to 60%. The onset of delirium, agitation, pain and dyspnea may contribute to reduce the success rate of non invasive ventilation treatment. The aim of this study is to assess the incidence and impact of delirium, agitation, pain and dyspnea on clinical outcomes in a population of patient admitted to Respiratory Intensive Care Unit undergoing Non-Invasive Mechanical Ventilation for Acute Respiratory Failure.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of Observation

Trials testing the same drug.

Other recruiting trials for Respiratory Failure

Currently open trials in the same condition.

Other University of Modena and Reggio Emilia trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03880084.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing